The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Indiplon     N-methyl-N-[3-(7-thiophen-2- ylcarbonyl-1,5...

Synonyms: SureCN75094, CHEMBL262075, NBI-34060, AC-2358, QC-3180, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

High impact information on Indiplon

  • Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors [1].
  • Using radioligand binding studies, indiplon inhibited the binding of [(3)H]Ro 15-1788 (flumazenil) to rat cerebellar and cerebral cortex membranes with high affinity (K(i) values of 0.55 and 0.45 nM, respectively) [2].
  • The pharmacokinetic profile of indiplon in both rat and mouse was consistent with its pharmacodynamic properties and indicated a rapid T(max), short t(1/2), and excellent blood-brain barrier penetration [3].

Analytical, diagnostic and therapeutic context of Indiplon

  • Two new agents, ramelteon, which was recently approved by the U.S. Food and Drug Administration for use in adults with insomnia, and immediate release and modified release indiplon, which is currently under investigation, have been effective in clinical trials [4].
  • Indiplon (NBI 34060; N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazolo[1,5-alpha]pyrimidin-7-yl]phenyl]acetamide), a novel pyrazolopyrimidine and high-affinity allosteric potentiator of GABA(A) receptor function, was profiled for its effects in rodents after oral administration [3].


  1. Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors. Petroski, R.E., Pomeroy, J.E., Das, R., Bowman, H., Yang, W., Chen, A.P., Foster, A.C. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  2. Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor. Sullivan, S.K., Petroski, R.E., Verge, G., Gross, R.S., Foster, A.C., Grigoriadis, D.E. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  3. In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic. Foster, A.C., Pelleymounter, M.A., Cullen, M.J., Lewis, D., Joppa, M., Chen, T.K., Bozigian, H.P., Gross, R.S., Gogas, K.R. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  4. Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. Ancoli-Israel, S. The Journal of clinical psychiatry. (2005) [Pubmed]
WikiGenes - Universities